Study of colistin resistance in hard-to-treat bacteria
Part of Infections clinical trials.
This trial looks at bacteria from hospital patients that are hard to treat because they resist many drugs, especially the antibiotic colistin. It aims to understand how these bacteria become resistant so doctors can better choose treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a bacterial infection that is resistant to many antibiotics.
- The bacteria causing your infection must be a type called gram-negative.
- You cannot have an infection caused by gram-positive bacteria.
- The bacteria must not be easily killed by the antibiotic carbapenem.
- Your samples must be from a single infection episode and not repeats.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving a medication (colistin) both through an IV and as a mist you breathe in works better for lung infections caused by bacteria that are hard to treat with standard antibiotics. It may help patients who have these tough bacteria and are in the hospital.
This study tests two different pairs of strong antibiotics to see which works better at clearing hard-to-treat bacterial infections that don't respond to standard drugs. You would receive one of these two combinations and be monitored for how well it works and any side effects.
This study tests different ways of giving the antibiotic colistin to patients in the ICU with infections that are hard to treat. The goal is to find the best dosing schedule to help you fight the infection more effectively.
This trial looks at cancer patients at Sohag Oncology Center who have infections caused by a specific type of hard-to-treat bacteria. It aims to understand how these bacteria become resistant to strong antibiotics.
This trial tests a medicine called colistimethate sodium for people in the hospital with a serious infection (pneumonia or bloodstream infection) caused by a resistant bacteria called CRE. The goal is to see if this antibiotic can effectively treat the infection.
This study tests different antibiotic combinations for severe infections caused by hard-to-treat Gram-negative bacteria (like Pseudomonas or Acinetobacter). The goal is to find the best treatment for bloodstream infections or pneumonia that started in the hospital.
Hear when a new Patients With Multi Drug Resistant Gram-negative Bacteria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.